Related Experiment Video

Updated: Nov 28, 2025

Generation of Human 3D Lung Tissue Cultures 3D-LTCs for Disease Modeling
05:47

Generation of Human 3D Lung Tissue Cultures 3D-LTCs for Disease Modeling

Published on: February 12, 2019

21.6K

The potential of Atorvastatin for chronic lung diseases therapy

Alaa S Tulbah1

  • 1Department of Pharmaceutics, College of Pharmacy, Umm Al Qura University, Makkah, Saudi Arabia.

Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society
|November 30, 2020
PubMed

Keywords:
%, PercentageAA, Allergic asthmaAP-1, Activator protein-1ATO, AtorvastatinAtorvastatinBALF, Bronchoalveolar lavage fluidCCL7, Chemokine ligand 7CI, Confidence intervalCOPD, Chronic obstructive pulmonary diseaseCRP, C-reactive proteinCS, Cigarettes smokeCYP3A4/5, Cytochrome Metabolic enzymes3A4/5FPP, FarnesylpyrophosphateG, GramGEF, Guanine nucleotide exchange factorsGGPP, GeranylgeranylpyrophosphateIL, InterleukinsInflammationInhaleLog P, Partition coefficientMMPs, Matrix-metalloproteaseMVA, Mevalonic acidNADPH, Nicotinamide adenine dinucleotide phosphateNCSCL, Non-small cell lung cancerNF-κB, Nuclear factor kappaNOS, Nitric oxide synthaseNaOH, Sodium hydroxideOATP, Organic anion transporting polypeptideOralOxidationPEG, Polyethylene glycolPPE, Porcine pancreatic elastaseROS, Reactive oxygen speciesRespiratory diseasesSAS, Supercritical antisolventSphK1, Sphingosine kinase 1TGF, Transforming growth factorTNF-a, Tumour necrosis factor alphaTSC, Tuberous sclerosisUDP, Uridine diphosphateUV, Ultraviolet lightVEGF, Vascular endothelial cell growth factorVLDL, Very low-density lipoproteinsWHO, World Health Organizationlog D, Coefficient values octanol/waterm2, Square metermg, Milligrammg/day, Milligram per dayml, MillilitrespH, Measure of the acidity or basicity of an aqueous solutionpKa, Dissociation constants, Secondv/v, Volume per volume°C/min, Temperature in degrees per minutesμM, Micromolarμg, Microgramμg/day, Microgram per dayμg/mL, Microgram per millilitre

More Related Videos

Unilateral Lung Volume Analysis Using Micro-CT for Enhanced Assessment of Pulmonary Fibrosis in Preclinical Models03:38

Unilateral Lung Volume Analysis Using Micro-CT for Enhanced Assessment of Pulmonary Fibrosis in Preclinical Models

Published on: June 20, 2025

638
Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure08:17

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

11.3K

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.2K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.9K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.8K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
566
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
332
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
990